3/26
03:24 pm
ctso
Cytosorbents (CTSO) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.
Low
Report
Cytosorbents (CTSO) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.
3/25
11:23 pm
ctso
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ... [Yahoo! Finance]
High
Report
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ... [Yahoo! Finance]
3/25
06:48 pm
ctso
Cytosorbents outlines cash flow breakeven path for second half of 2026 amid international sales growth [Seeking Alpha]
Low
Report
Cytosorbents outlines cash flow breakeven path for second half of 2026 amid international sales growth [Seeking Alpha]
3/25
04:42 pm
ctso
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/25
04:05 pm
ctso
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
High
Report
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
3/19
09:44 am
ctso
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
Medium
Report
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
3/5
07:22 am
ctso
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
Low
Report
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/5
07:00 am
ctso
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Low
Report
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
1/13
04:05 am
ctso
Cytosorbents (NASDAQ:CTSO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Cytosorbents (NASDAQ:CTSO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
1/12
08:34 am
ctso
Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Medium
Report
Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
1/12
07:20 am
ctso
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update [Yahoo! Finance]
Medium
Report
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update [Yahoo! Finance]
1/12
07:00 am
ctso
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
Medium
Report
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update